Prot #RM-110: Phase 1b/2 Open-label Study to Evaluate the Safety, Tolerability and Efficacy of Rivoceranib or Trifluridine/Tipiracil as Monotherapies and Rivoceranib and Trifluridine/Tipiracil as Combination Therapy in Subjects with Metastatic Colorectal

Project: Research project

Project Details

StatusFinished
Effective start/end date7/16/20 → 7/16/23

Funding

  • Medpace Clinical Research LLC ((OE) Prot #RM-110 // (OE) Prot #RM-110)
  • Elevar Therapeutics, Inc. ((OE) Prot #RM-110 // (OE) Prot #RM-110)